reference/23448910

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23448910

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	709
issn	1468-2060 0003-4967
issueIdentifier	5
pageRange	702-709
publicationName	Annals of the Rheumatic Diseases
startingPage	702
bibliographicCitation	Mease PJ, Ory P, Sharp JT, Ritchlin CT, Van den Bosch F, Wellborne F, Birbara C, Thomson GT, Perdok RJ, Medich J, Wong RL, Gladman DD. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis. 2009 May;68(5):702–9. PMID: 18684743; PMCID: PMC2663711.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b8fd3e08af1987dcb8a7dcc65b8a730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7214670bbd9a0bb5a5587b081f7d46a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d170e8849caadb7851829ae295688381 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f94edd0d948376f907c359d00f2c644c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9895247e485bf43caee9c91de4f4c11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_628b18c6f9de86165ee7306cf0d97498 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e393b0a69765443ed468f4a7271b4933 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e263f2a45dd9498558a06198f24809aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b731c1fa92d1181834954a72fd225405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9252bbcba38f5006ac3ea20ee8128f59 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc1b8eac2644a02c8adbf43ea92246a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6ac8030034adf254c236e6c6ea1dcf5
date	2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1136/ard.2008.092767 https://pubmed.ncbi.nlm.nih.gov/18684743 https://pubmed.ncbi.nlm.nih.gov/PMC2663711
isPartOf	https://portal.issn.org/resource/ISSN/1468-2060 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640 https://portal.issn.org/resource/ISSN/0003-4967
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0022150 http://id.nlm.nih.gov/mesh/M0422769 http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D015535Q000188 http://id.nlm.nih.gov/mesh/D018501Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014409Q000037 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D011565Q000473 http://id.nlm.nih.gov/mesh/D011565Q000188 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015535Q000000981 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D000068879 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018501Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D015535Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D011859
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8214 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9238 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9007 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9751

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129476173

Total number of triples: 70.